Longevity medicine is an emerging clinical discipline focused on extending healthspan by identifying and addressing the biological drivers of aging before they cause disease, rather than waiting to treat conditions after they appear. It sits at the intersection of preventive medicine, functional medicine, and the aging-biology research covered elsewhere on this site.

How It Differs From Conventional Medicine

Conventional medicine is largely organized around diagnosing and treating disease once symptoms or abnormal test results appear. Longevity medicine takes a different starting point: it treats biological age and the risk of future age-related disease as things that can be measured and modified proactively, often years before a conventional diagnosis would occur.

  • Conventional care: reactive, disease-focused, organized around standard reference ranges for lab values.
  • Longevity medicine: proactive, risk-focused, often uses optimized (narrower) target ranges and additional biomarker panels not part of routine care.
  • Conventional care: annual physicals and standard blood panels.
  • Longevity medicine: expanded diagnostics including epigenetic age testing, advanced cardiovascular imaging, continuous glucose monitoring, VO2 max testing, and body composition analysis.

What a Longevity Medicine Program Typically Includes

Programs vary considerably, but common components include:

  • Comprehensive baseline testing (bloodwork, body composition, cardiovascular risk markers, sometimes genetic and epigenetic testing).
  • Personalized exercise prescriptions, often emphasizing both strength training and Zone 2 cardiovascular work.
  • Nutrition guidance tailored to metabolic markers rather than generic dietary advice.
  • Sleep optimization protocols and, in some cases, sleep study referrals.
  • Ongoing monitoring and retesting to track biomarker trends over time.
  • In some clinics, pharmaceutical interventions being studied for longevity effects (such as metformin or rapamycin), typically prescribed off-label.

Where the Evidence Stands

The individual components of most longevity medicine programs (exercise, sleep, nutrition, standard preventive screening) are supported by strong, long-established evidence. What is newer and less validated is the packaging of these components into a distinct clinical specialty, along with some of the add-on diagnostics and off-label pharmaceutical use that characterize higher-end programs.

Epigenetic age tests, for example, are a genuinely useful research tool, but their clinical utility for guiding individual treatment decisions is still being established. Off-label use of drugs like rapamycin for longevity purposes is based on promising animal and mechanistic data, but robust long-term human trials for healthy adults are still in progress.

Who Practices Longevity Medicine

Longevity medicine is practiced by a mix of physicians (often trained in internal medicine, family medicine, or endocrinology), functional medicine practitioners, and increasingly by dedicated longevity clinics and membership-based concierge practices. There is no single board certification governing the field, which means the quality, rigor, and evidence-basis of programs varies significantly between providers.

Important Caveat

Longevity medicine is an evolving field, and not all providers offering longevity-focused care apply the same evidentiary standards. Nothing in this article constitutes medical advice or a recommendation for any specific program, test, or medication. Discuss any longevity-focused testing or treatment with a licensed healthcare professional, and ask providers directly about the evidence base behind specific recommendations.